Back to Search
PREETHI NAMBI, MBBS, MD
MBBS, MD
Internal Medicine Physician
NPI: 1265687974IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
P0918(TX)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2004
Research & Publications (20)
Multislice computed tomography of a repaired anomalous left coronary artery arising from the pulmonary artery.
PMID 19156251·Tex Heart Inst J·2008
5-case
Previous left main coronary artery dissection: detected upon multislice computed tomography.
PMID 18941597·Tex Heart Inst J·2008
5-case
Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
PMID 19394832·Bioorg Med Chem·2009
7-preclinical
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.
PMID 19318684·J Lipid Res·2009
7-preclinical
Biarylether amide quinolines as liver X receptor agonists.
PMID 19162487·Bioorg Med Chem·2009
7-preclinical
Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
PMID 18973288·J Med Chem·2008
7-preclinical
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.
PMID 18925943·J Transl Med·2008
3-trial
Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
PMID 18023179·Bioorg Med Chem Lett·2008
7-preclinical
GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats.
PMID 17420776·Br J Pharmacol·2007
7-preclinical
Adipocyte fatty acid-binding protein (aP2), a newly identified LXR target gene, is induced by LXR agonists in human THP-1 cells.
PMID 17396233·Mol Cell Biochem·2007
8-other
Further modification on phenyl acetic acid based quinolines as liver X receptor modulators.
PMID 17391964·Bioorg Med Chem·2007
7-preclinical
Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.
PMID 17034119·J Med Chem·2006
7-preclinical
Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
PMID 17010152·J Thromb Haemost·2006
7-preclinical
Identification and characterization of triosephosphate isomerase that specifically interacts with the integrin alphaIIb cytoplasmic domain.
PMID 16859644·Biochem Pharmacol·2006
8-other
Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
PMID 16825483·Mol Pharmacol·2006
7-preclinical
The occurrence of nymphal stage of Linguatula serrata in water buffaloes (Bubalus bubalis): nymphal morphometry and lymph node pathology.
PMID 16300658·J Vet Med A Physiol Pathol Clin Med·2005
7-preclinical
Fasciola gigantica cathepsin-L cysteine proteinase in the detection of early experimental fasciolosis in ruminants.
PMID 16222528·Parasitol Res·2005
7-preclinical
Vaccination of buffaloes with Fasciola gigantica recombinant fatty acid binding protein.
PMID 15986249·Parasitol Res·2005
7-preclinical
Sirolimus upregulates aP2 expression in human monocytes and macrophages.
PMID 15686734·Transplant Proc·2004
8-other
Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
PMID 15292374·J Lipid Res·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6630 DE MOSS DR
HOUSTON, TX 77074 - Phone
- (713) 272-2600
Quick Facts
- NPI
- 1265687974
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile